We established the following significant (p < 0.05) correlations of CBF and DKI with Ki-67 and Bcl-2 in the combined glioma patient group (n = 50): in ROI1 (highly perfused enhancing tumor part) Ki67 LI—CBF (rs = 0.363), Ki67 LI—AWF (rs = 0.343), Ki67 LI—RK (rs = 0.324); in ROI2 (perifocal infiltrative edema zone) Bcl2—MK (rs = −0.444), Bcl2—RK (rs = −0.427). The gene discussed is BCL2; the disease is central nervous system cancer.